Astrazeneca Pharma India informs about loss of share certificates

19 Nov 2022 Evaluate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Astrazeneca Pharma India has informed that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services have informed the Company on the attached request for Loss of Share Certificate from the claimant.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

6336.90 48.00 (0.76%)
22-Nov-2024 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1215.35
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 947.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.